Skip to content
Episode 153 - September 5, 2025 episode artwork

Sep 5, 2025 1 hr 1 min

Episode 153 - September 5, 2025

from Biotech Hangout Hosted by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

On this week’s episode, hosts Paul Matteis, Sam Fazeli, John Maraganore, and Graig Suvannaveijh kick off the discussion with a more positive look at the sector and some of the fundamental factors at play. The group then shares an overview of Sanofi’s 10% stock fall on the back of positive Phase 3 eczema data with worries about the Dupixent patent expiry. The discussion then turns to Insmed, a company that has had a monster year with the stock up 100% and a market cap of over $30 billion market. On the data front, the group highlights ApoC3 data from Ionis and Arrowhead at the European Society of Cardiology Congress 2025, which leads into a discussion around ASO versus RNAi. With multiple obesity readouts in recent weeks, the group theorizes on whether obesity is a zero sum game. It’s a big year ahead for AD readouts and the hosts summarizes some important catalysts on the horizon. Other discussion topics include the launch of Corsera Health for cardiovascular prevention, Trump’s Truth Social post on vaccine data, RFK Jr in front of congress, and public concern around access to vaccines. This episode aired on September 5, 2025.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Episode 153 - September 5, 2025

0:00 1:01:06

No transcript yet.

Requests help us decide what to transcribe next.

Talking Biotech with Dr. Kevin Folta Kevin Folta Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering.Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050.Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics. State of Digital Clinical Trials Podcast Veeva State of Digital Clinical Trials is a Veeva podcast hosted by Manny Vazquez, Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric? The Biotech Startups Podcast Excedr The Biotech Startups Podcast by Excedr features weekly conversations with founders, scientists, and investors driving biotech innovation. Host Jon Chee dives into the challenges of building biotech startups, from pre-seed to IPO. New episodes every Monday and Thursday. Healthcare NOW Radio Podcast Network - Discussions on healthcare including technology, innovation, policy, data security, telehealth and more. Visit HealthcareNOWRadio.com Healthcare NOW Radio and Podcast Network - Radio and Podcasts for the Healthcare Industry RADIO FOR THE HEALTHCARE INDUSTRYHealthcare NOW Radio and Podcast Network offers discussions on the latest developments and trends impacting the industry including: health tech, health IT, healthcare innovation, healthcare policy, healthcare data security, telehealth, interoperability, biotech, med tech, value-based care, pharma, healthcare compliance, and much more. Shows are hosted by industry thought leaders. Guests are a "who's who" across the healthcare spectrum. The listening audience is predominantly physician and hospital-based, and the healthcare industry at large.

Frequently asked questions

How long is this episode of Biotech Hangout?

This episode is 1 hour and 1 minute long.

When was this Biotech Hangout episode published?

This episode was published on September 5, 2025.

Can I download this Biotech Hangout episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.